查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1677245

牛、豬和豬生殖疾病市場按疾病類型、動物類型、診斷類型、治療類型、預防和控制、最終用戶分類 - 2025 年至 2030 年全球預測

Cattle & Porcine/Swine Reproductive Diseases Market by Disease Type, Animal Type, Diagnosis Type, Treatment Type, Prevention And Control, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年牛、豬和豬生殖疾病市場價值為 7.7972 億美元，預計到 2025 年將成長至 8.1933 億美元，複合年成長率為 5.29%，到 2030 年將達到 10.6253 億美元。

主要市場統計數據
基準年 2024 年 7.7972億美元
預計 2025 年 8.1933億美元
預測年份 2030 10.6253億美元
複合年成長率（%） 5.29％

全球畜牧業在防治牛、豬生殖疾病方面面臨前所未有的挑戰與機會。在技​​術快速進步和流行病學模式不斷演變的時代，相關人員被迫重新思考其疾病管理方法。報告首先全面了解生殖疾病及其對畜牧業生產力、經濟穩定性和整個供應鏈的影響。該分析強調了新興病原體與傳統挑戰之間的相互關係，鼓勵行業專業人士採取創新策略。日益加深的全球化、不斷發展的法律規範和技術突破構成了我們討論的背景。它認知到不同行業（包括集約化農業經營、研究組織和獸醫服務供應商）面臨的不同挑戰，並呼籲制定既尊重當地特徵又尊重更廣泛行業活力的客製化解決方案。透過提供當前情勢的全面概況，本介紹為深入探討變革性轉變、關鍵細分見解和策略建議奠定了基礎，從而使決策者掌握推動有影響力的變革所需的知識。

改變牛、豬和豬生殖疾病市場

近年來，牛和豬生殖醫學領域正在發生變革性的變化。數位工具和精準診斷方法的迅速普及重新定義了疾病爆發的檢測和管理方式。現代影像技術和分子檢測補充了傳統的診斷方法並支持早期療育策略以遏制感染的傳播。此外，不斷發展的生物安全通訊協定不僅可以限制病原體的引入，還可以提高牲畜族群的復原力。進階資料分析和機器學習的整合為預測模型鋪平了道路，為傳統的被動措施提供了主動的替代方案。這一演變也受到世界各地監管改革的影響。行業相關人員現在願意投資於旨在降低風險的研究和合作。加強疫苗接種計劃以及創新的治療方法進一步改變了情況，使我們能夠有效地對抗新發和流行疾病。總體而言，這些重大變化強調了敏捷和回應策略的重要性，並要求從孤立的干涉措施轉向利用最新技術和綜合醫療實踐的全面、資料主導的方法。

針對疾病管理的關鍵細分見解

詳細的細分研究揭示了生殖疾病的不同方面是如何演變的。當考慮疾病類型時，市場會透過分類進行徹底研究，包括細菌感染、真菌感染、寄生蟲感染和病毒感染。在細菌感染疾病中，布氏桿菌症、鉤端螺旋體病和結核病由於其巨大的經濟影響而受到關注。真菌感染包括皮膚絲狀菌症和黴菌毒素中毒，而寄生蟲病如球蟲、弓形蟲病和禽流感對於制定診斷和干涉通訊協定至關重要。口蹄疫、豬繁殖與呼吸症候群、豬瘟等感染疾病持續構成威脅，需要強而有力的控制措施。

透過區分牛和豬並根據動物類型對市場進行分類，實現進一步的細分。這裡對肉牛和乳牛以及繁殖、育肥和保育豬的區分對於制定具體的管理和治療通訊協定至關重要。分析涵蓋診斷技術；培養、影像、分子生物學技術（如 PCR 和 LAMP 檢測）、血清學測試（如 AGID、ELISA 和 SNT）為準確的疾病識別提供了詳細的藍圖。治療策略分為替代療法、醫療介入（包括抗生素、抗寄生蟲藥物和抗病毒藥物）、手術介入和疫苗接種。此外，基於預防和控制的市場區隔突顯了生物安全措施、生殖管理、衛生通訊協定和營養計畫的重要性。依最終用戶（包括農場、研究機構和獸醫診所）進行細分，進一步完善有效疾病管理所需的策略方法。共同這些見解構成了針對不同生殖疾病環境中特定挑戰的針對性策略的支柱。

目錄

第 1 章 簡介

第2章調查方法

第3章執行摘要

第4章 市場概況

第5章 市場洞察

  • 市場動態
    • 驅動程式
      • 全球對肉類和乳製品的需求不斷成長，推動了有效疾病控制的需求。
      • 加強生物安全措施，重點防止牲畜感染疾病傳播
      • 農民對於採用有效的疾病預防方法的認知正在不斷提高。
    • 限制因素
      • 獸醫服務和治療生殖疾病的費用高昂
    • 機會
      • 製藥和農業部門繼續夥伴關係以加強疾病管理解決方案
      • 人工智慧工具增強診斷能力，為牛和豬的健康問題提供更快的結果
    • 任務
      • 農村地區獲得獸醫服務的機會有限，限制了疾病的有效控制。
  • 市場區隔分析
    • 最終用戶：研究實驗室在牛和豬生殖健康方面不斷取得進展
    • 疾病類型：加強布氏桿菌症、鉤端螺旋體病和結核病對牛和豬生殖疾病影響的研究
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 經濟
    • 社會的
    • 技術的
    • 合法的
    • 環境

第6章牛、豬及豬生殖系統疾病市場（依疾病類型）

  • 細菌感染疾病
    • 布氏桿菌症
    • 鉤端螺旋體病
    • 結核
  • 黴菌感染疾病
    • 皮膚絲狀菌症
    • 黴菌毒素中毒症
  • 寄生蟲感染
    • 球蟲
    • 弓形蟲病
    • 旋毛蟲病
  • 病毒感染
    • 口蹄疫
    • 豬繁殖與呼吸綜合症（PRRS）
    • 豬霍亂

第7章牛、豬和豬生殖系統疾病市場（依動物類型）

  • 牛
    • 肉牛
    • 乳牛
  • 豬
    • 養豬業
    • 肥育豬
    • 養豬場裡的豬

第 8 章牛、豬和豬生殖道疾病市場（依診斷類型）

  • 栽培技術
    • 細菌培養
    • 病毒分離
  • 診斷影像
    • 超音波
    • X 光影像
  • 分子方法
    • LAMP 檢測
    • PCR
  • 血清學檢測
    • AGID
    • 酵素連結免疫吸附試驗
    • SNT

第9章牛、豬和豬生殖系統疾病市場按治療類型

  • 替代療法
    • 草藥療法
    • 同類療法
  • 藥品
    • 抗生素
    • 驅蟲藥
    • 抗病毒藥物
  • 手術介入
    • 矯正手術
    • 預防性手術
  • 接種疫苗
    • 去活化疫苗
    • 減毒活疫苗

第10章牛、豬及豬生殖疾病預防控制市場

  • 生物安全措施
    • 消毒方法
    • 檢疫通訊協定
  • 繁殖管理
    • 人工授精技術
    • 基因選擇程式
  • 衛生管理
    • 衛生通訊協定
    • 廢棄物管理
  • 營養管理
    • 均衡飲食計劃
    • 有機飼料選擇

第 11 章牛、豬和豬生殖道疾病市場（按最終用戶）

  • 農場
  • 研究組織
  • 獸醫診所

12. 美國牛、豬、豬生殖系統疾病市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

13. 亞太地區牛、豬和豬生殖疾病市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

14. 歐洲、中東和非洲牛、豬和豬生殖疾病市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第15章 競爭格局

  • 2024 年市場佔有率分析
  • FPNV 定位矩陣，2024 年
  • 競爭情境分析
  • 戰略分析與建議

公司列表

  • Anicon Labor GmbH
  • Biogenesis Bago SA
  • Biomin Holding GmbH
  • Boehringer Ingelheim Animal Health
  • CEVA Sante Animale
  • Dechra Pharmaceuticals PLC
  • Eco Animal Health Group plc
  • Elanco Animal Health Incorporated
  • Hipra
  • Huvepharma EOOD
  • Huvepharma Inc.
  • IDEXX Laboratories, Inc.
  • Innovacyn, Inc.
  • Kaneka Corporation（via subsidiary）
  • Medovent GmbH
  • Merck Animal Health
  • MSD Animal Health
  • Neogen Corporation
  • Norbrook Laboratories Ltd.
  • Vetoquinol Global
  • Virbac SA
  • Zoetis Inc.
Product Code: MRR-094390F3E231

The Cattle & Porcine/Swine Reproductive Diseases Market was valued at USD 779.72 million in 2024 and is projected to grow to USD 819.33 million in 2025, with a CAGR of 5.29%, reaching USD 1,062.53 million by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 779.72 million
Estimated Year [2025] USD 819.33 million
Forecast Year [2030] USD 1,062.53 million
CAGR (%) 5.29%

The global livestock industry is confronting unprecedented challenges and opportunities as it grapples with reproductive diseases in cattle and swine. In an era defined by rapid technological advancements and evolving epidemiological patterns, stakeholders are compelled to reassess their approaches to disease management. This report opens by establishing a comprehensive understanding of reproductive diseases, elaborating on their impacts on animal productivity, economic stability, and the overall supply chain. The analysis highlights the interplay between emerging pathogens and traditional challenges, encouraging industry experts to adopt innovative strategies. A backdrop of intensified globalization, evolving regulatory frameworks, and technological breakthroughs serves as the context for our discussion. We also acknowledge the diverse challenges faced by different sectors, whether intensive farming operations, research institutions, or veterinary service providers, calling for tailored solutions that respect both regional specificities and the broader industry dynamic. By presenting a thorough overview of the current landscape, this introduction lays the groundwork for a deeper exploration of transformative shifts, key segmentation insights, and strategic recommendations designed to equip decision-makers with the knowledge necessary to drive impactful change.

Transformative Shifts in the Reproductive Disease Landscape

Recent years have ushered in transformative shifts within the realm of reproductive health in cattle and swine. Rapid adoption of digital tools and precise diagnostic methods has redefined how disease outbreaks are detected and managed. Modern imaging techniques and molecular assays have supplemented traditional diagnostics, empowering early intervention strategies that curb the spread of infections. Moreover, evolving biosecurity protocols are not only limiting the introduction of pathogens, but also enhancing the resilience of livestock populations. The integration of advanced data analytics and machine learning has paved the way for predictive modeling, offering a proactive alternative to conventional reactive measures. This evolution is further influenced by global regulatory reforms, which are pushing for standardized practices across different regions. Industry stakeholders are now more willing to invest in research and collaborative frameworks aimed at mitigating risks. Enhanced vaccination programs alongside innovative treatment regimens have further restructured the landscape, ensuring that both emerging and endemic diseases are countered effectively. Overall, these sweeping changes underscore the importance of agility and responsive strategies, and call for a shift from isolated interventions to comprehensive, data-driven approaches that harness the power of modern technology and integrated health management practices.

Key Segmentation Insights for Targeted Disease Management

An in-depth segmentation study provides clarity on how different facets of reproductive diseases are evolving. When considering disease type, the market is thoroughly studied through classifications that include bacterial, fungal, parasitic, and viral infections. Within bacterial infections, conditions such as brucellosis, leptospirosis, and tuberculosis demand focused attention due to their significant economic impact. Fungal challenges include dermatophytosis and mycotoxicosis, while parasitic infestations such as coccidiosis, toxoplasmosis, and trichinosis are critical in shaping the diagnostic and intervention protocols. Viral infections, exemplified by Foot and Mouth Disease, Porcine Reproductive and Respiratory Syndrome, and Swine Fever, pose a constant threat that necessitates robust control measures.

Further segmentation is achieved by categorizing the market based on animal type, differentiating between cattle and swine. Here, beef and dairy cattle are addressed separately from breeding swine, finishing pigs, and nursery pigs-a delineation that is crucial for devising specific management and treatment protocols. The analysis extends to diagnostic techniques where culturing methods, diagnostic imaging, molecular methods like PCR and LAMP assays, and serological tests such as AGID, ELISA, and SNT provide a detailed roadmap for accurate disease identification. Treatment strategies are dissected into alternative therapies, pharmaceutical interventions including antibiotics, antiparasitics and antivirals, surgical interventions, and vaccinations. Additionally, market segmentation based on prevention and control underscores the importance of biosecurity measures, breeding management, hygiene protocols, and nutrition plans. The segmentation by end-user, which includes farms, research institutions, and veterinary clinics, further refines the strategic approach required for effective disease management. Together, these insights form the backbone for targeted strategies that address specific challenges across the diverse landscape of reproductive diseases.

Based on Disease Type, market is studied across Bacterial Infections, Fungal Infections, Parasitic Infestations, and Viral Infections. The Bacterial Infections is further studied across Brucellosis, Leptospirosis, and Tuberculosis. The Fungal Infections is further studied across Dermatophytosis and Mycotoxicosis. The Parasitic Infestations is further studied across Coccidiosis, Toxoplasmosis, and Trichinosis. The Viral Infections is further studied across Foot And Mouth Disease, Porcine Reproductive And Respiratory Syndrome (PRRS), and Swine Fever.

Based on Animal Type, market is studied across Cattle and Swine. The Cattle is further studied across Beef Cattle and Dairy Cattle. The Swine is further studied across Breeding Swine, Finishing Pigs, and Nursery Pigs.

Based on Diagnosis Type, market is studied across Culturing Techniques, Diagnostic Imaging, Molecular Methods, and Serological Tests. The Culturing Techniques is further studied across Bacterial Culture and Viral Isolation. The Diagnostic Imaging is further studied across Ultrasonography and X-Ray Imaging. The Molecular Methods is further studied across LAMP Assays and PCR. The Serological Tests is further studied across AGID, ELISA, and SNT.

Based on Treatment Type, market is studied across Alternative Therapies, Pharmaceuticals, Surgical Interventions, and Vaccinations. The Alternative Therapies is further studied across Herbal Treatments and Homoeopathy. The Pharmaceuticals is further studied across Antibiotics, Antiparasitics, and Antivirals. The Surgical Interventions is further studied across Corrective Surgeries and Prophylactic Surgeries. The Vaccinations is further studied across Inactivated Vaccines and Live Attenuated Vaccines.

Based on Prevention And Control, market is studied across Biosecurity Measures, Breeding Management, Hygiene Management, and Nutritional Management. The Biosecurity Measures is further studied across Disinfection Practices and Quarantine Protocols. The Breeding Management is further studied across Artificial Insemination Techniques and Genetic Selection Programs. The Hygiene Management is further studied across Sanitation Protocols and Waste Management. The Nutritional Management is further studied across Balanced Diet Plans and Organic Feed Options.

Based on End-User, market is studied across Farms, Research Institutions, and Veterinary Clinics.

Key Regional Insights Across Global Markets

Understanding the regional nuances is integral in crafting strategies that align with local demands and operational challenges. In the Americas, robust animal health frameworks and advanced agricultural practices underscore the importance of continuous innovation in mitigating disease impacts. The Americas serve as a benchmark for integrating cutting-edge diagnostics and treatment protocols, with substantial investments in research and development. In contrast, the combined market regions of Europe, the Middle East, and Africa illustrate a unique blend of historical disease challenges and modern interventions. These regions are characterized by diverse regulatory environments and a varied prevalence of reproductive diseases that call for flexible yet comprehensive management strategies. Meanwhile, the Asia-Pacific region, with its rapid industrial growth and evolving farming techniques, is marked by a rising demand for advanced biosecurity measures and sustainable disease prevention programs. The dynamic nature of each geographical segment necessitates localized studies that consider market-specific disease profiles, regulatory differences, and evolving epidemiological patterns, thus providing a holistic view of the global landscape. Each region's unique approach not only offers lessons in strategic adaptability but also underscores the potential for collaborative innovation in tackling pervasive reproductive health challenges.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Steering Innovation and Market Growth

The market is driven by a competitive landscape that features a range of global and regional leaders, each contributing through innovative research and robust product portfolios. Prominent players such as Anicon Labor GmbH and Biogenesis Bago SA are at the forefront of developing advanced diagnostics and treatment methodologies tailored to reproductive diseases. Entities like Biomin Holding GmbH and Boehringer Ingelheim Animal Health continue to set benchmarks in vaccine development and comprehensive disease management strategies. CEVA Sante Animale and Dechra Pharmaceuticals PLC have been instrumental in bridging scientific research with practical implementation, while Eco Animal Health Group plc and Elanco Animal Health Incorporated consistently lead in deploying next-generation health solutions. Notable companies including Hipra, Huvepharma EOOD, and Huvepharma Inc. harness cutting-edge research to push the boundaries of disease prevention and control. IDEXX Laboratories, Inc. alongside Innovacyn, Inc. have built strong reputations through innovative diagnostic technologies, further enhanced by the contributions of Kaneka Corporation via its subsidiaries and Medovent GmbH. Industry giants like Merck Animal Health, MSD Animal Health, Neogen Corporation, Norbrook Laboratories Ltd., Vetoquinol Global, Virbac S.A., and Zoetis Inc. round out the competitive spectrum, consistently raising the bar for quality and efficacy. Their collaborative efforts reflect the dynamism within this sector and highlight a commitment to leveraging innovation to effectively address current and future challenges in reproductive disease management.

The report delves into recent significant developments in the Cattle & Porcine/Swine Reproductive Diseases Market, highlighting leading vendors and their innovative profiles. These include Anicon Labor GmbH, Biogenesis Bago SA, Biomin Holding GmbH, Boehringer Ingelheim Animal Health, CEVA Sante Animale, Dechra Pharmaceuticals PLC, Eco Animal Health Group plc, Elanco Animal Health Incorporated, Hipra, Huvepharma EOOD, Huvepharma Inc., IDEXX Laboratories, Inc., Innovacyn, Inc., Kaneka Corporation (via subsidiary), Medovent GmbH, Merck Animal Health, MSD Animal Health, Neogen Corporation, Norbrook Laboratories Ltd., Vetoquinol Global, Virbac S.A., and Zoetis Inc.. Actionable Recommendations for Industry Leaders

Industry leaders are encouraged to adopt a multi-pronged approach that integrates advanced diagnostic and treatment methodologies with preventative and sustainable management practices. A strategic investment in research aimed at early detection and rapid response protocols is paramount, as is the expansion of collaborative networks that bring together cross-disciplinary expertise. It is essential to harness precise data analytics, deploying predictive modeling tools to forecast disease outbreaks and streamline intervention strategies. Investing in modern technology and digital transformation not only enhances operational efficiency but also strengthens the resilience of health management frameworks. Leaders should also focus on adapting their strategies to suit diverse market segments, considering the unique disease profiles and operational challenges specific to cattle versus swine, and northern as well as emerging markets. Emphasis on continuous training and robust communication channels among veterinary teams will ensure that innovations in diagnosis and treatment are effectively implemented. Furthermore, fostering partnerships with academic institutions and research bodies can drive novel insights and refine best practices in disease management. By embracing these recommendations, decision-makers can better mitigate the impending risks associated with reproductive diseases while optimizing the overall productivity and sustainability of the livestock industry.

Conclusion: Charting the Future of Disease Management

In conclusion, the landscape of reproductive diseases in cattle and swine is characterized by rapid scientific and technological evolution, which provides both remarkable opportunities and significant challenges. The integration of advanced diagnostics, segmented approaches to disease management, and regional nuances have collectively set the stage for a more proactive and precise strategy in combating these health issues. Companies leading the charge with innovative solutions are redefining the metrics of success within this competitive market. Although the challenges remain formidable, the emerging trends in early detection, targeted therapy, and robust prevention protocols inspire a confident outlook for the future. This comprehensive analysis reinforces the need for cohesive, data-driven, and forward-thinking approaches that can adapt to the evolving disease landscape. Moving forward, stakeholders must collaborate strategically, investing in technology and partnerships that not only ensure animal health and productivity but also safeguard the economic vitality of the livestock industry.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing global demand for meat and dairy products is driving the need for effective disease management
      • 5.1.1.2. Rising in biosecurity measures focus on preventing the spread of infectious diseases in livestock populations
      • 5.1.1.3. Growing awareness among farmers enhancing the adoption of effective disease prevention methods
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of veterinary services and treatments for reproductive diseases
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing partnerships between pharmaceutical companies and agricultural sectors enhancing disease control solutions
      • 5.1.3.2. Enhancing diagnostics through AI-driven tools to provide rapid results for cattle and porcine health issues
    • 5.1.4. Challenges
      • 5.1.4.1. Limited access to veterinary services in rural areas restricts effective disease management
  • 5.2. Market Segmentation Analysis
    • 5.2.1. End-User: Ongoing advancement of cattle & swine reproductive health in research institutions
    • 5.2.2. Disease Type: Growing research on the impact of Brucellosis, Leptospirosis, and Tuberculosis on Cattle & Porcine Reproductive Diseases
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Cattle & Porcine/Swine Reproductive Diseases Market, by Disease Type

  • 6.1. Introduction
  • 6.2. Bacterial Infections
    • 6.2.1. Brucellosis
    • 6.2.2. Leptospirosis
    • 6.2.3. Tuberculosis
  • 6.3. Fungal Infections
    • 6.3.1. Dermatophytosis
    • 6.3.2. Mycotoxicosis
  • 6.4. Parasitic Infestations
    • 6.4.1. Coccidiosis
    • 6.4.2. Toxoplasmosis
    • 6.4.3. Trichinosis
  • 6.5. Viral Infections
    • 6.5.1. Foot And Mouth Disease
    • 6.5.2. Porcine Reproductive And Respiratory Syndrome (PRRS)
    • 6.5.3. Swine Fever

7. Cattle & Porcine/Swine Reproductive Diseases Market, by Animal Type

  • 7.1. Introduction
  • 7.2. Cattle
    • 7.2.1. Beef Cattle
    • 7.2.2. Dairy Cattle
  • 7.3. Swine
    • 7.3.1. Breeding Swine
    • 7.3.2. Finishing Pigs
    • 7.3.3. Nursery Pigs

8. Cattle & Porcine/Swine Reproductive Diseases Market, by Diagnosis Type

  • 8.1. Introduction
  • 8.2. Culturing Techniques
    • 8.2.1. Bacterial Culture
    • 8.2.2. Viral Isolation
  • 8.3. Diagnostic Imaging
    • 8.3.1. Ultrasonography
    • 8.3.2. X-Ray Imaging
  • 8.4. Molecular Methods
    • 8.4.1. LAMP Assays
    • 8.4.2. PCR
  • 8.5. Serological Tests
    • 8.5.1. AGID
    • 8.5.2. ELISA
    • 8.5.3. SNT

9. Cattle & Porcine/Swine Reproductive Diseases Market, by Treatment Type

  • 9.1. Introduction
  • 9.2. Alternative Therapies
    • 9.2.1. Herbal Treatments
    • 9.2.2. Homoeopathy
  • 9.3. Pharmaceuticals
    • 9.3.1. Antibiotics
    • 9.3.2. Antiparasitics
    • 9.3.3. Antivirals
  • 9.4. Surgical Interventions
    • 9.4.1. Corrective Surgeries
    • 9.4.2. Prophylactic Surgeries
  • 9.5. Vaccinations
    • 9.5.1. Inactivated Vaccines
    • 9.5.2. Live Attenuated Vaccines

10. Cattle & Porcine/Swine Reproductive Diseases Market, by Prevention And Control

  • 10.1. Introduction
  • 10.2. Biosecurity Measures
    • 10.2.1. Disinfection Practices
    • 10.2.2. Quarantine Protocols
  • 10.3. Breeding Management
    • 10.3.1. Artificial Insemination Techniques
    • 10.3.2. Genetic Selection Programs
  • 10.4. Hygiene Management
    • 10.4.1. Sanitation Protocols
    • 10.4.2. Waste Management
  • 10.5. Nutritional Management
    • 10.5.1. Balanced Diet Plans
    • 10.5.2. Organic Feed Options

11. Cattle & Porcine/Swine Reproductive Diseases Market, by End-User

  • 11.1. Introduction
  • 11.2. Farms
  • 11.3. Research Institutions
  • 11.4. Veterinary Clinics

12. Americas Cattle & Porcine/Swine Reproductive Diseases Market

  • 12.1. Introduction
  • 12.2. Argentina
  • 12.3. Brazil
  • 12.4. Canada
  • 12.5. Mexico
  • 12.6. United States

13. Asia-Pacific Cattle & Porcine/Swine Reproductive Diseases Market

  • 13.1. Introduction
  • 13.2. Australia
  • 13.3. China
  • 13.4. India
  • 13.5. Indonesia
  • 13.6. Japan
  • 13.7. Malaysia
  • 13.8. Philippines
  • 13.9. Singapore
  • 13.10. South Korea
  • 13.11. Taiwan
  • 13.12. Thailand
  • 13.13. Vietnam

14. Europe, Middle East & Africa Cattle & Porcine/Swine Reproductive Diseases Market

  • 14.1. Introduction
  • 14.2. Denmark
  • 14.3. Egypt
  • 14.4. Finland
  • 14.5. France
  • 14.6. Germany
  • 14.7. Israel
  • 14.8. Italy
  • 14.9. Netherlands
  • 14.10. Nigeria
  • 14.11. Norway
  • 14.12. Poland
  • 14.13. Qatar
  • 14.14. Russia
  • 14.15. Saudi Arabia
  • 14.16. South Africa
  • 14.17. Spain
  • 14.18. Sweden
  • 14.19. Switzerland
  • 14.20. Turkey
  • 14.21. United Arab Emirates
  • 14.22. United Kingdom

15. Competitive Landscape

  • 15.1. Market Share Analysis, 2024
  • 15.2. FPNV Positioning Matrix, 2024
  • 15.3. Competitive Scenario Analysis
    • 15.3.1. Merck Animal Health launch SENSEHUB cow calf for enhanced breeding success
    • 15.3.2. NutriQuest and Modulant Biosciences partner to innovate swine disease control
    • 15.3.3. EpiVax and Zoetis collaborate to enhance swine vaccine effectiveness with CircoMatch tool
  • 15.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anicon Labor GmbH
  • 2. Biogenesis Bago SA
  • 3. Biomin Holding GmbH
  • 4. Boehringer Ingelheim Animal Health
  • 5. CEVA Sante Animale
  • 6. Dechra Pharmaceuticals PLC
  • 7. Eco Animal Health Group plc
  • 8. Elanco Animal Health Incorporated
  • 9. Hipra
  • 10. Huvepharma EOOD
  • 11. Huvepharma Inc.
  • 12. IDEXX Laboratories, Inc.
  • 13. Innovacyn, Inc.
  • 14. Kaneka Corporation (via subsidiary)
  • 15. Medovent GmbH
  • 16. Merck Animal Health
  • 17. MSD Animal Health
  • 18. Neogen Corporation
  • 19. Norbrook Laboratories Ltd.
  • 20. Vetoquinol Global
  • 21. Virbac S.A.
  • 22. Zoetis Inc.

LIST OF FIGURES

  • FIGURE 1. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET MULTI-CURRENCY
  • FIGURE 2. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET MULTI-LANGUAGE
  • FIGURE 3. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET RESEARCH PROCESS
  • FIGURE 4. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 21. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 23. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. EUROPE, MIDDLE EAST & AFRICA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. EUROPE, MIDDLE EAST & AFRICA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 29. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET DYNAMICS
  • TABLE 7. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BRUCELLOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY LEPTOSPIROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TUBERCULOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DERMATOPHYTOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MYCOTOXICOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COCCIDIOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TOXOPLASMOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TRICHINOSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FOOT AND MOUTH DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE FEVER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BEEF CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DAIRY CATTLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING SWINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FINISHING PIGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NURSERY PIGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL ISOLATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ULTRASONOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY X-RAY IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY LAMP ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY AGID, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ELISA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SNT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 55. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 57. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HERBAL TREATMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 58. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HOMOEOPATHY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 59. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 60. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 61. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANTIBIOTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 62. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANTIPARASITICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 63. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANTIVIRALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 64. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 65. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 66. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CORRECTIVE SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 67. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PROPHYLACTIC SURGERIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 68. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 69. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 70. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY INACTIVATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 71. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 72. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
  • TABLE 73. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
  • TABLE 74. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 75. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISINFECTION PRACTICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 76. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY QUARANTINE PROTOCOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 77. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
  • TABLE 78. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 79. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ARTIFICIAL INSEMINATION TECHNIQUES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 80. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY GENETIC SELECTION PROGRAMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 81. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 82. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 83. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SANITATION PROTOCOLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 84. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY WASTE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 85. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 86. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 87. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BALANCED DIET PLANS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 88. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ORGANIC FEED OPTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 89. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 90. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FARMS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 92. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY RESEARCH INSTITUTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 93. GLOBAL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 94. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 96. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 97. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
  • TABLE 98. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 99. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
  • TABLE 101. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
  • TABLE 102. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 104. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 105. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
  • TABLE 106. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 107. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 109. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 110. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 111. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
  • TABLE 112. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
  • TABLE 113. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
  • TABLE 114. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 115. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 116. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 117. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. AMERICAS CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 119. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 121. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 122. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
  • TABLE 123. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 124. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
  • TABLE 126. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
  • TABLE 127. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 129. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 130. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
  • TABLE 131. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 132. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 134. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 135. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 136. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
  • TABLE 137. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
  • TABLE 138. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
  • TABLE 139. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 140. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 141. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 142. ARGENTINA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 145. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 146. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
  • TABLE 147. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 148. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
  • TABLE 150. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
  • TABLE 151. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 153. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 154. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
  • TABLE 155. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 156. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 158. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 159. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 160. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
  • TABLE 161. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
  • TABLE 162. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
  • TABLE 163. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 164. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 165. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 166. BRAZIL CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 167. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 169. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 170. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
  • TABLE 171. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 172. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
  • TABLE 174. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
  • TABLE 175. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 177. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 178. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
  • TABLE 179. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 180. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 182. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 183. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 184. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
  • TABLE 185. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
  • TABLE 186. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
  • TABLE 187. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 188. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 189. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 190. CANADA CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 193. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 194. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
  • TABLE 195. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 196. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
  • TABLE 198. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
  • TABLE 199. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 201. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 202. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
  • TABLE 203. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 204. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 206. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 207. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 208. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
  • TABLE 209. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
  • TABLE 210. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
  • TABLE 211. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 212. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 213. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 214. MEXICO CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 217. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 218. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
  • TABLE 219. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 220. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
  • TABLE 222. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
  • TABLE 223. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED STATES CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 240. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DISEASE TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BACTERIAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 242. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY FUNGAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 243. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PARASITIC INFESTATIONS, 2018-2030 (USD MILLION)
  • TABLE 244. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VIRAL INFECTIONS, 2018-2030 (USD MILLION)
  • TABLE 245. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ANIMAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 246. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CATTLE, 2018-2030 (USD MILLION)
  • TABLE 247. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SWINE, 2018-2030 (USD MILLION)
  • TABLE 248. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSIS TYPE, 2018-2030 (USD MILLION)
  • TABLE 249. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY CULTURING TECHNIQUES, 2018-2030 (USD MILLION)
  • TABLE 250. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY DIAGNOSTIC IMAGING, 2018-2030 (USD MILLION)
  • TABLE 251. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY MOLECULAR METHODS, 2018-2030 (USD MILLION)
  • TABLE 252. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SEROLOGICAL TESTS, 2018-2030 (USD MILLION)
  • TABLE 253. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY ALTERNATIVE THERAPIES, 2018-2030 (USD MILLION)
  • TABLE 255. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PHARMACEUTICALS, 2018-2030 (USD MILLION)
  • TABLE 256. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY SURGICAL INTERVENTIONS, 2018-2030 (USD MILLION)
  • TABLE 257. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY VACCINATIONS, 2018-2030 (USD MILLION)
  • TABLE 258. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY PREVENTION AND CONTROL, 2018-2030 (USD MILLION)
  • TABLE 259. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BIOSECURITY MEASURES, 2018-2030 (USD MILLION)
  • TABLE 260. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY BREEDING MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY HYGIENE MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY NUTRITIONAL MANAGEMENT, 2018-2030 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC CATTLE & PORCINE/SWINE REPRODUCTIVE DISEASES MARKET SIZE, BY COUN